GlassScriptPhysician profile
Cassie Ann Mcnamee
NPI 1083457766
$742.24
in general payments reported to CMS, 2019-2025
17 companies · $533 in 2025
The $533 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $210 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $742.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $105.20 | 2024-2025 | Airsupra, Farxiga |
| Amgen INC. | $84.87 | 2024-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $77.27 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $76.10 | 2025 | |
| Glaxosmithkline, LLC. | $55.78 | 2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Pfizer INC. | $49.08 | 2024-2025 | |
| Seqirus USA INC | $35.75 | 2025 | Fluad, Flucelvax |
| Hologic Sales and Service, LLC | $35.01 | 2025 | Aptima |
| Exact Sciences Corporation | $32.76 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $30.01 | 2024 | |
| Phathom Pharmaceuticals, INC. | $29.35 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $28.60 | 2024 | |
| Janssen Pharmaceuticals, INC | $26.09 | 2025 | Spravato |
| Novo Nordisk INC | $21.54 | 2024 | Ozempic |
| Biogen, INC. | $20.05 | 2025 | Zurzuvae |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $18.29 | 2025 | Austedo Xr |
| Merck Sharp & Dohme LLC | $16.49 | 2024 | Pifeltro, Delstrigo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassie Mcnamee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.